Endocrine oncology

Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma?

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

MFD was less common in childhood and adolescent patients with PTC than adults and was not a predictor of poor outcome on multivariate analysis, with excellent long-term outcomes in all patients with PTC. MFD does not appear to warrant completion thyroidectomy in childhood and adolescent patients selected for lobectomy.

Study context

Population
Patients with papillary thyroid carcinoma (PTC) undergoing surgery (1986–2021) at Memorial Sloan Kettering Cancer Center
Exposure
Multifocal (multifocal disease (MFD)) vs unifocal disease (UFD) in childhood and adolescent PTC; childhood and adolescent vs adult PTC
  • Childhood and adolescentn = 283
  • Adultsn = 5,564reference
Outcome
Incidence of MFD in childhood and adolescent vs adult PTC, and whether MFD predicts poorer outcomes in childhood and adolescent PTC
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Incidence of MFD

P = 0.002

Observational data: associations, not effects.

Further findings

Outcomes of MFD vs UFD in childhood and adolescent PTC · median follow-up 68 months

Overall survival in both groups
100%
Similar tumor stage and PTC subtype; no significant difference in histopathologic features
No significant difference in 5-year recurrence-free probability
No significant difference in 5-year contralateral lobe PTC-free probability after lobectomy
MFD not a predictor for recurrence on multivariate analysis

Original publication

Is Multifocality a Predictor of Poor Outcome in Childhood and Adolescent Papillary Thyroid Carcinoma? J Clin Endocrinol Metab. Published 23 June 2023. doi:10.1210/clinem/dgad369

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.